Summary

Veterinary Hematology Analyzers Market – Scope of Report
TMR’s report on the global veterinary hematology analyzers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global veterinary hematology analyzers market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary hematology analyzers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary hematology analyzers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary hematology analyzers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary hematology analyzers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary hematology analyzers market.

The report delves into the competitive landscape of the global veterinary hematology analyzers market. Key players operating in the global veterinary hematology analyzers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary hematology analyzers market profiled in this report.

Key Questions Answered in Global veterinary hematology analyzers Market Report
• What is the sales/revenue generated by veterinary hematology analyzers across all regions during the forecast period?
• What are the opportunities in the global veterinary hematology analyzers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Veterinary Hematology Analyzers Market – Research Objectives and Research Approach
The comprehensive report on the global veterinary hematology analyzers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary hematology analyzers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary hematology analyzers market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Veterinary Hematology Analyzers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Hematology Analyzers Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Veterinary Hematology Analyzers Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Table Top Analyzers
6.3.1.1. Fully Automatic Analyzers
6.3.1.2. Semi-automatic Analyzers
6.3.2. Point-of-Care Analyzers
6.3.2.1. Cartridge-based
6.3.2.2. Others (Direct Sample-based)
6.4. Market Attractiveness Analysis, by Product
7. Global Veterinary Hematology Analyzers Market Analysis and Forecast, by Analysis Parameter
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Analysis Parameter, 2020-2034
7.3.1. 2-Part WBC Differential
7.3.2. 3-Part WBC Differential
7.3.3. 5-Part WBC Differential
7.3.4. Others
7.4. Market Attractiveness Analysis, by Analysis Parameter
8. Global Veterinary Hematology Analyzers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Research Institutes
8.3.2. Veterinary Diagnostic Centers
8.3.3. Veterinary Hospitals and Clinics
8.3.4. Others (Point-of-Care Testing, In-house Testing, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Veterinary Hematology Analyzers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Veterinary Hematology Analyzers Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2020-2034
10.3.1. Table Top Analyzers
10.3.1.1. Fully Automatic Analyzers
10.3.1.2. Semi-automatic Analyzers
10.3.2. Point-of-Care Analyzers
10.3.2.1. Cartridge-based
10.3.2.2. Others (Direct Sample-based)
10.4. Market Value Forecast, by Analysis Parameter, 2020-2034
10.4.1. 2-Part WBC Differential
10.4.2. 3-Part WBC Differential
10.4.3. 5-Part WBC Differential
10.4.4. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Research Institutes
10.5.2. Veterinary Diagnostic Centers
10.5.3. Veterinary Hospitals and Clinics
10.5.4. Others (Point-of-Care Testing, In-house Testing, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Analysis Parameter
10.7.3. By End-user
10.7.4. By Country
11. Europe Veterinary Hematology Analyzers Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2020-2034
11.3.1. Table Top Analyzers
11.3.1.1. Fully Automatic Analyzers
11.3.1.2. Semi-automatic Analyzers
11.3.2. Point-of-Care Analyzers
11.3.2.1. Cartridge-based
11.3.2.2. Others (Direct Sample-based)
11.4. Market Value Forecast, by Analysis Parameter, 2020-2034
11.4.1. 2-Part WBC Differential
11.4.2. 3-Part WBC Differential
11.4.3. 5-Part WBC Differential
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Research Institutes
11.5.2. Veterinary Diagnostic Centers
11.5.3. Veterinary Hospitals and Clinics
11.5.4. Others (Point-of-Care Testing, In-house Testing, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Analysis Parameter
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Veterinary Hematology Analyzers Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2020-2034
12.3.1. Table Top Analyzers
12.3.1.1. Fully Automatic Analyzers
12.3.1.2. Semi-automatic Analyzers
12.3.2. Point-of-Care Analyzers
12.3.2.1. Cartridge-based
12.3.2.2. Others (Direct Sample-based)
12.4. Market Value Forecast, by Analysis Parameter, 2020-2034
12.4.1. 2-Part WBC Differential
12.4.2. 3-Part WBC Differential
12.4.3. 5-Part WBC Differential
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Research Institutes
12.5.2. Veterinary Diagnostic Centers
12.5.3. Veterinary Hospitals and Clinics
12.5.4. Others (Point-of-Care Testing, In-house Testing, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Analysis Parameter
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Veterinary Hematology Analyzers Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2020-2034
13.3.1. Table Top Analyzers
13.3.1.1. Fully Automatic Analyzers
13.3.1.2. Semi-automatic Analyzers
13.3.2. Point-of-Care Analyzers
13.3.2.1. Cartridge-based
13.3.2.2. Others (Direct Sample-based)
13.4. Market Value Forecast, by Analysis Parameter, 2020-2034
13.4.1. 2-Part WBC Differential
13.4.2. 3-Part WBC Differential
13.4.3. 5-Part WBC Differential
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Research Institutes
13.5.2. Veterinary Diagnostic Centers
13.5.3. Veterinary Hospitals and Clinics
13.5.4. Others (Point-of-Care Testing, In-house Testing, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Analysis Parameter
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Veterinary Hematology Analyzers Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2020-2034
14.3.1. Table Top Analyzers
14.3.1.1. Fully Automatic Analyzers
14.3.1.2. Semi-automatic Analyzers
14.3.2. Point-of-Care Analyzers
14.3.2.1. Cartridge-based
14.3.2.2. Others (Direct Sample-based)
14.4. Market Value Forecast, by Analysis Parameter, 2020-2034
14.4.1. 2-Part WBC Differential
14.4.2. 3-Part WBC Differential
14.4.3. 5-Part WBC Differential
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Research Institutes
14.5.2. Veterinary Diagnostic Centers
14.5.3. Veterinary Hospitals and Clinics
14.5.4. Others (Point-of-Care Testing, In-house Testing, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Analysis Parameter
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Siemens Healthineers
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. IDEXX Laboratories, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Heska Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Abaxis, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Sysmex Corporation
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Mindray Medical International Ltd.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Boule Medical AB
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Qreserve, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Drew Scientific, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Urit Medical
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Rayto Life and Analytical Sciences Co., Ltd.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Woodley Equipment Company Ltd.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Scil animal care company GmbH
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. HORIBA Medical
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
15.3.15. Diatron MI PLC
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Financial Overview
15.3.15.5. Strategic Overview
15.3.16. Clindiag Systems Co., Ltd.
15.3.16.1. Company Overview
15.3.16.2. Product Portfolio
15.3.16.3. SWOT Analysis
15.3.16.4. Financial Overview
15.3.16.5. Strategic Overview
15.3.17. HemoCue AB
15.3.17.1. Company Overview
15.3.17.2. Product Portfolio
15.3.17.3. SWOT Analysis
15.3.17.4. Financial Overview
15.3.17.5. Strategic Overview